{
  "id": 771884,
  "title": "A new ADHD drug targets three brain chemicals instead of two. Here's what that means",
  "url": "https://urgent.news/2026/08/13/a-new-adhd-drug-targets-three-brain-chemicals-instead-of-two-heres-771884",
  "topic": "science",
  "section": "Science",
  "published": "2026-08-13T12:40:03.000Z",
  "source": {
    "name": "Medical Xpress",
    "slug": "medical-xpress",
    "url": "https://medicalxpress.com/news/2026-08-adhd-drug-brain-chemicals.html"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new medicine for attention-deficit/hyperactivity disorder (ADHD) has just entered the treatment toolbox: centanafadine, a once-daily tablet sold under the brand name Simtriyo.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "The Conversation AU",
        "title": "A new ADHD drug targets three brain chemicals instead of two. Here’s what that means",
        "url": "https://urgent.news/2026/08/13/a-new-adhd-drug-targets-three-brain-chemicals-instead-of-two-heres",
        "published": "2026-08-13T03:52:03.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}